BioCatalystWatch
PSTVWorkspace / PSTV / OverviewCompany library
PLUS THERAPEUTICS, INC. logo

PLUS THERAPEUTICS, INC.

PLUS THERAPEUTICS, INC. (PSTV)

Website

Price
Market cap
Next catalystExpected Q4 2026REYOBIQ — ReSPECT-LM multidose study · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

REYOBIQ (rhenium Re186 obisbemeda)

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

REYOBIQ (rhenium Re186 obisbemeda)REYOBIQ — ReSPECT-LM multidose study

Radiopharmaceutical

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

REYOBIQ (rhenium Re186 obisbemeda)REYOBIQ — ReSPECT-LM multidose study

Radiopharmaceutical

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

REYOBIQ (rhenium Re186 obisbemeda)

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

188RNL-BAM

Radiopharmaceutical

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PSTV PR & News

PSTV SEC archive